PGx Testing Labs Concerned by FDA’s Statements, Actions

This is a synopsis of two in-depth articles in the Sept. 3, 2019 issue of THE DARK REPORT (TDR). The full articles are available to members of The Dark Intelligence Group. CEO SUMMARY: Since April, 2019, the federal Food and Drug Administration (FDA) has taken steps that target clinical laboratories that perform pharmacogenetic (PGx) tests. …

PGx Testing Labs Concerned by FDA’s Statements, Actions Read More »

To access this post, you must purchase The Dark Report.

PGx Testing Labs Concerned by FDA’s Statements, Actions

Federal agency is telling PGx testing labs to assess if their PGx lab tests comply with regulations

Comments

TABLE OF CONTENTS

Need A Group Membership? Company Discounts are Available!